TLR2 and acute myeloid leukemia: The Expression of Toll-like Receptors in Patients with Acute Myeloid Leukemia Treated With Induction Chemotherapy have been studied (Rybka et al., 2015; Ramzi et al., 2018); however the impact of Toll like receptors 2, 4 polymorphism on the AML patients outcome are not previously studied.